Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Corso

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Blood|June 30, 2010
Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signalingMelania Tesio, Karin Golan, Simona Corso, et al.
Cancer Research|July 10, 2025
AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal CancerDaniela Conticelli, Marco Volante, Filippo Pietrantonio, et al.
Science Advances|March 15, 2024
Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of <i>Arid1a</i> mutationsAlessandro D'Ambrosio, Davide Bressan, Elisa Ferracci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2017
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control StudyFilippo Pietrantonio, Giovanni Fucà, Federica Morano, et al.
Cancer Discovery|June 5, 2013
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancerAlberto Bardelli, Simona Corso, Andrea Bertotti, et al.
Neoplasia (New York, N.Y.)|March 26, 2018
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived XenograftsSimona Corso, Marilisa Cargnelutti, Stefania Durando, et al.
Cancer Research|May 2, 2023
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP InhibitorsAnnalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 23, 2021
Personalized therapeutic strategies in HER2-driven gastric cancerStefano Ughetto, Cristina Migliore, Filippo Pietrantonio, et al.
Gut|October 30, 2025
Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapyTaotao Sheng, Raghav Sundar, Supriya Srivastava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Optimized EGFR Blockade Strategies in <i>EGFR</i> Addicted Gastroesophageal AdenocarcinomasSimona Corso, Filippo Pietrantonio, Maria Apicella, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Blood|June 30, 2010
Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signalingMelania Tesio, Karin Golan, Simona Corso, et al.
Cancer Research|July 10, 2025
AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal CancerDaniela Conticelli, Marco Volante, Filippo Pietrantonio, et al.
Science Advances|March 15, 2024
Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of <i>Arid1a</i> mutationsAlessandro D'Ambrosio, Davide Bressan, Elisa Ferracci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2017
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control StudyFilippo Pietrantonio, Giovanni Fucà, Federica Morano, et al.
Cancer Discovery|June 5, 2013
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancerAlberto Bardelli, Simona Corso, Andrea Bertotti, et al.
Neoplasia (New York, N.Y.)|March 26, 2018
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived XenograftsSimona Corso, Marilisa Cargnelutti, Stefania Durando, et al.
Cancer Research|May 2, 2023
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP InhibitorsAnnalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 23, 2021
Personalized therapeutic strategies in HER2-driven gastric cancerStefano Ughetto, Cristina Migliore, Filippo Pietrantonio, et al.
Gut|October 30, 2025
Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapyTaotao Sheng, Raghav Sundar, Supriya Srivastava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Optimized EGFR Blockade Strategies in <i>EGFR</i> Addicted Gastroesophageal AdenocarcinomasSimona Corso, Filippo Pietrantonio, Maria Apicella, et al.
Pageof 6